BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GS-0151 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of GS-0151\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06902519-6380@assetmemo.bio
DTSTAMP:20261121T005657Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:GS-0151: Phase 1 readout est. (NCT06902519)
DESCRIPTION:GS-0151\, phase 1\, Rheumatoid Arthritis.\nStudy: Study of GS-0
 151 in Participants With Rheumatoid Arthritis\nEstimated primary completio
 n: March 2027. This is a ClinicalTrials.gov estimate\, not a confirmed rea
 dout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/gs-015
 1#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT06
 902519
URL:https://assetmemo.bio/drug/gs-0151#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
